AbbVie
ABBV
#34
Rank
โ‚น33.873 T
Marketcap
โ‚น19,151
Share price
0.67%
Change (1 day)
33.30%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น578.09 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น61.16 Billion. , an increase over its 2024 earnings that were of โ‚น347.00 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น616.02 B77.53%
2024 โ‚น347.00 B-40.54%
2023 โ‚น583.62 B-53.62%
2022 โ‚น1.258 T3.76%
2021 โ‚น1.212 T282.25%
2020 โ‚น317.30 B-59.67%
2019 โ‚น786.81 B62.13%
2018 โ‚น485.29 B-32.74%
2017 โ‚น721.54 B-1.99%
2016 โ‚น736.20 B18.65%
2015 โ‚น620.51 B180.5%
2014 โ‚น221.21 B-55.57%
2013 โ‚น497.90 B-6.86%
2012 โ‚น534.59 B56.05%
2011 โ‚น342.56 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น951.72 B 54.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.402 T 290.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น838.17 B 36.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น145.34 B-76.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น914.84 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น871.04 B 41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.317 T 113.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น924.06 B 50.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น59.43 B-90.35%๐Ÿ‡บ๐Ÿ‡ธ USA